1 Biologics and Biosimilars Market Overview 1.1 Biologics and Biosimilars Product Scope 1.2 Biologics and Biosimilars Segment by Type 1.2.1 Global Biologics and Biosimilars Sales by Type (2020-2026) 1.2.2 Monoclonal Antibodies 1.2.3 Interferon 1.2.4 Erythropoietin 1.2.5 Insulin 1.2.6 Vaccines 1.2.7 Others 1.3 Biologics and Biosimilars Segment by Application 1.3.1 Global Biologics and Biosimilars Sales Comparison by Application (2020-2026) 1.3.2 Tumor 1.3.3 Diabetes 1.3.4 Cardiovascular 1.3.5 Hemophilia 1.3.6 Others 1.4 Biologics and Biosimilars Market Estimates and Forecasts (2015-2026) 1.4.1 Global Biologics and Biosimilars Sales Growth Rate (2015-2026) 1.4.2 Global Biologics and Biosimilars Revenue and Growth Rate (2015-2026) 1.4.3 Global Biologics and Biosimilars Price Trends (2015-2026) 2 Biologics and Biosimilars Estimate and Forecast by Region 2.1 Global Biologics and Biosimilars Market Size by Region: 2015 VS 2020 VS 2026 2.2 Global Biologics and Biosimilars Retrospective Market Scenario by Region (2015-2020) 2.2.1 Global Biologics and Biosimilars Sales Market Share by Region (2015-2020) 2.2.2 Global Biologics and Biosimilars Revenue Market Share by Region (2015-2020) 2.3 Global Biologics and Biosimilars Market Estimates and Forecasts by Region (2021-2026) 2.3.1 Global Biologics and Biosimilars Sales Estimates and Forecasts by Region (2021-2026) 2.3.2 Global Biologics and Biosimilars Revenue Forecast by Region (2021-2026) 2.4 Geographic Market Analysis: Market Facts & Figures 2.4.1 United States Biologics and Biosimilars Estimates and Projections (2015-2026) 2.4.2 Europe Biologics and Biosimilars Estimates and Projections (2015-2026) 2.4.3 China Biologics and Biosimilars Estimates and Projections (2015-2026) 2.4.4 Japan Biologics and Biosimilars Estimates and Projections (2015-2026) 2.4.5 Southeast Asia Biologics and Biosimilars Estimates and Projections (2015-2026) 2.4.6 India Biologics and Biosimilars Estimates and Projections (2015-2026) 3 Global Biologics and Biosimilars Competition Landscape by Players 3.1 Global Top Biologics and Biosimilars Players by Sales (2015-2020) 3.2 Global Top Biologics and Biosimilars Players by Revenue (2015-2020) 3.3 Global Biologics and Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologics and Biosimilars as of 2019) 3.4 Global Biologics and Biosimilars Average Price by Company (2015-2020) 3.5 Manufacturers Biologics and Biosimilars Manufacturing Sites, Area Served, Product Type 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3.7 Primary Interviews with Key Biologics and Biosimilars Players (Opinion Leaders) 4 Global Biologics and Biosimilars Market Size by Type 4.1 Global Biologics and Biosimilars Historic Market Review by Type (2015-2020) 4.1.1 Global Biologics and Biosimilars Sales Market Share by Type (2015-2020) 4.1.2 Global Biologics and Biosimilars Revenue Market Share by Type (2015-2020) 4.1.3 Global Biologics and Biosimilars Price by Type (2015-2020) 4.2 Global Biologics and Biosimilars Market Estimates and Forecasts by Type (2021-2026) 4.2.1 Global Biologics and Biosimilars Sales Forecast by Type (2021-2026) 4.2.2 Global Biologics and Biosimilars Revenue Forecast by Type (2021-2026) 4.2.3 Global Biologics and Biosimilars Price Forecast by Type (2021-2026) 5 Global Biologics and Biosimilars Market Size by Application 5.1 Global Biologics and Biosimilars Historic Market Review by Application (2015-2020) 5.1.1 Global Biologics and Biosimilars Sales Market Share by Application (2015-2020) 5.1.2 Global Biologics and Biosimilars Revenue Market Share by Application (2015-2020) 5.1.3 Global Biologics and Biosimilars Price by Application (2015-2020) 5.2 Global Biologics and Biosimilars Market Estimates and Forecasts by Application (2021-2026) 5.2.1 Global Biologics and Biosimilars Sales Forecast by Application (2021-2026) 5.2.2 Global Biologics and Biosimilars Revenue Forecast by Application (2021-2026) 5.2.3 Global Biologics and Biosimilars Price Forecast by Application (2021-2026) 6 United States Biologics and Biosimilars Market Facts & Figures 6.1 United States Biologics and Biosimilars Sales Market Share by Company (2015-2020) 6.2 United States Biologics and Biosimilars Sales Market Share by Type (2015-2020) 6.3 United States Biologics and Biosimilars Sales Market Share by Application (2015-2020) 7 Europe Biologics and Biosimilars Market Facts & Figures 7.1 Europe Biologics and Biosimilars Sales Market Share by Company (2015-2020) 7.2 Europe Biologics and Biosimilars Sales Market Share by Type (2015-2020) 7.3 Europe Biologics and Biosimilars Sales Market Share by Application (2015-2020) 8 China Biologics and Biosimilars Market Facts & Figures 8.1 China Biologics and Biosimilars Sales Market Share by Company (2015-2020) 8.2 China Biologics and Biosimilars Sales Market Share by Type (2015-2020) 8.3 China Biologics and Biosimilars Sales Market Share by Application (2015-2020) 9 Japan Biologics and Biosimilars Market Facts & Figures 9.1 Japan Biologics and Biosimilars Sales Market Share by Company (3015-3030) 9.2 Japan Biologics and Biosimilars Sales Market Share by Type (2015-2020) 9.3 Japan Biologics and Biosimilars Sales Market Share by Application (2015-2020) 10 Southeast Asia Biologics and Biosimilars Market Facts & Figures 10.1 Southeast Asia Biologics and Biosimilars Sales Market Share by Company (2015-2020) 10.2 Southeast Asia Biologics and Biosimilars Sales Market Share by Type (2015-2020) 10.3 Southeast Asia Biologics and Biosimilars Sales Market Share by Application (2015-2020) 11 India Biologics and Biosimilars Market Facts & Figures 11.1 India Biologics and Biosimilars Sales Market Share by Company (2015-2020) 11.2 India Biologics and Biosimilars Sales Market Share by Type (2015-2020) 11.3 India Biologics and Biosimilars Sales Market Share by Application (2015-2020) 12 Company Profiles and Key Figures in Biologics and Biosimilars Business 12.1 Roche 12.1.1 Roche Corporation Information 12.1.2 Roche Business Overview 12.1.3 Roche Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020) 12.1.4 Roche Biologics and Biosimilars Products Offered 12.1.5 Roche Recent Development 12.2 Amgen 12.2.1 Amgen Corporation Information 12.2.2 Amgen Business Overview 12.2.3 Amgen Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020) 12.2.4 Amgen Biologics and Biosimilars Products Offered 12.2.5 Amgen Recent Development 12.3 AbbVie 12.3.1 AbbVie Corporation Information 12.3.2 AbbVie Business Overview 12.3.3 AbbVie Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020) 12.3.4 AbbVie Biologics and Biosimilars Products Offered 12.3.5 AbbVie Recent Development 12.4 Sanofi-Aventis 12.4.1 Sanofi-Aventis Corporation Information 12.4.2 Sanofi-Aventis Business Overview 12.4.3 Sanofi-Aventis Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020) 12.4.4 Sanofi-Aventis Biologics and Biosimilars Products Offered 12.4.5 Sanofi-Aventis Recent Development 12.5 Johnson & Johnson 12.5.1 Johnson & Johnson Corporation Information 12.5.2 Johnson & Johnson Business Overview 12.5.3 Johnson & Johnson Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020) 12.5.4 Johnson & Johnson Biologics and Biosimilars Products Offered 12.5.5 Johnson & Johnson Recent Development 12.6 Pfizer 12.6.1 Pfizer Corporation Information 12.6.2 Pfizer Business Overview 12.6.3 Pfizer Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020) 12.6.4 Pfizer Biologics and Biosimilars Products Offered 12.6.5 Pfizer Recent Development 12.7 Novo Nordisk 12.7.1 Novo Nordisk Corporation Information 12.7.2 Novo Nordisk Business Overview 12.7.3 Novo Nordisk Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020) 12.7.4 Novo Nordisk Biologics and Biosimilars Products Offered 12.7.5 Novo Nordisk Recent Development 12.8 Eli Lilly 12.8.1 Eli Lilly Corporation Information 12.8.2 Eli Lilly Business Overview 12.8.3 Eli Lilly Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020) 12.8.4 Eli Lilly Biologics and Biosimilars Products Offered 12.8.5 Eli Lilly Recent Development 12.9 Novartis 12.9.1 Novartis Corporation Information 12.9.2 Novartis Business Overview 12.9.3 Novartis Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020) 12.9.4 Novartis Biologics and Biosimilars Products Offered 12.9.5 Novartis Recent Development 12.10 Merck 12.10.1 Merck Corporation Information 12.10.2 Merck Business Overview 12.10.3 Merck Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020) 12.10.4 Merck Biologics and Biosimilars Products Offered 12.10.5 Merck Recent Development 12.11 3sbio 12.11.1 3sbio Corporation Information 12.11.2 3sbio Business Overview 12.11.3 3sbio Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020) 12.11.4 3sbio Biologics and Biosimilars Products Offered 12.11.5 3sbio Recent Development 12.12 Changchun High Tech 12.12.1 Changchun High Tech Corporation Information 12.12.2 Changchun High Tech Business Overview 12.12.3 Changchun High Tech Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020) 12.12.4 Changchun High Tech Biologics and Biosimilars Products Offered 12.12.5 Changchun High Tech Recent Development 12.13 CP Guojian 12.13.1 CP Guojian Corporation Information 12.13.2 CP Guojian Business Overview 12.13.3 CP Guojian Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020) 12.13.4 CP Guojian Biologics and Biosimilars Products Offered 12.13.5 CP Guojian Recent Development 12.14 Biotech 12.14.1 Biotech Corporation Information 12.14.2 Biotech Business Overview 12.14.3 Biotech Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020) 12.14.4 Biotech Biologics and Biosimilars Products Offered 12.14.5 Biotech Recent Development 12.15 Gelgen 12.15.1 Gelgen Corporation Information 12.15.2 Gelgen Business Overview 12.15.3 Gelgen Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020) 12.15.4 Gelgen Biologics and Biosimilars Products Offered 12.15.5 Gelgen Recent Development 12.16 Innovent 12.16.1 Innovent Corporation Information 12.16.2 Innovent Business Overview 12.16.3 Innovent Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020) 12.16.4 Innovent Biologics and Biosimilars Products Offered 12.16.5 Innovent Recent Development 12.17 Dong Bao 12.17.1 Dong Bao Corporation Information 12.17.2 Dong Bao Business Overview 12.17.3 Dong Bao Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020) 12.17.4 Dong Bao Biologics and Biosimilars Products Offered 12.17.5 Dong Bao Recent Development 12.18 Ganlee 12.18.1 Ganlee Corporation Information 12.18.2 Ganlee Business Overview 12.18.3 Ganlee Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020) 12.18.4 Ganlee Biologics and Biosimilars Products Offered 12.18.5 Ganlee Recent Development 13 Biologics and Biosimilars Manufacturing Cost Analysis 13.1 Biologics and Biosimilars Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Key Raw Materials Price Trend 13.1.3 Key Suppliers of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.3 Manufacturing Process Analysis of Biologics and Biosimilars 13.4 Biologics and Biosimilars Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers 14.1 Marketing Channel 14.2 Biologics and Biosimilars Distributors List 14.3 Biologics and Biosimilars Customers 15 Market Dynamics 15.1 Biologics and Biosimilars Market Trends 15.2 Biologics and Biosimilars Opportunities and Drivers 15.3 Biologics and Biosimilars Market Challenges 15.4 Biologics and Biosimilars Market Restraints 15.5 Porter's Five Forces Analysis 16 Research Findings and Conclusion 17 Appendix 17.1 Research Methodology 17.1.1 Methodology/Research Approach 17.1.2 Data Source 17.2 Author List 17.3 Disclaimer

List of Tables Table 1. Global Biologics and Biosimilars Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million) Table 2. Global Biologics and Biosimilars Sales (K Units) Comparison by Application (2020-2026) (US$ Million) Table 3. Global Market Biologics and Biosimilars Market Size (US$ Million) by Region:2015 VS 2020 &2026 Table 4. Global Biologics and Biosimilars Sales (K Units) by Region (2015-2020) Table 5. Global Biologics and Biosimilars Sales Market Share by Region (2015-2020) Table 6. Global Biologics and Biosimilars Revenue (US$ Million) Market Share by Region (2015-2020)) Table 7. Global Biologics and Biosimilars Revenue Share by Region (2015-2020) Table 8. Global Biologics and Biosimilars Sales (K Units) Forecast by Region (2021-2026) Table 9. Global Biologics and Biosimilars Sales Market Share Forecast by Region (2021-2026) Table 10. Global Biologics and Biosimilars Revenue (US$ Million) Forecast by Region (2021-2026) Table 11. Global Biologics and Biosimilars Revenue Share Forecast by Region (2021-2026) Table 12. Global Biologics and Biosimilars (K Units) of Key Companies (2015-2020) Table 13. Global Biologics and Biosimilars Sales Share by Company (2015-2020) Table 14. Global Biologics and Biosimilars Revenue (US$ Million) by Company (2015-2020) Table 15. Global Biologics and Biosimilars Revenue Share by Company (2015-2020) Table 16. Global Biologics and Biosimilars by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologics and Biosimilars as of 2019) Table 17. Global Biologics and Biosimilars Average Price (USD/Unit) of Key Company (2015-2020) Table 18. Manufacturers Biologics and Biosimilars Manufacturing Sites and Area Served Table 19. Manufacturers Biologics and Biosimilars Product Type Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans Table 21. Main Points Interviewed from Key Biologics and Biosimilars Players Table 22. Global Biologics and Biosimilars Sales (K Units) by Type (2015-2020) Table 23. Global Biologics and Biosimilars Sales Share by Type (2015-2020) Table 24. Global Biologics and Biosimilars Revenue (US$ Million) Market Share by Type (2015-2020) Table 25. Global Biologics and Biosimilars Price (K Units) by Type (2015-2020) Table 26. Global Biologics and Biosimilars Sales Share by Type (2021-2026) Table 27. Global Biologics and Biosimilars Revenue (US$ Million) Market Share by Type (2021-2026) Table 28. Global Biologics and Biosimilars Revenue Share by Type (2021-2026) Table 29. Global Biologics and Biosimilars Price (K Units) by Type (2021-2026) Table 30. Global Biologics and Biosimilars Sales (K Units) by Application (2015-2020) Table 31. Global Biologics and Biosimilars Sales Share by Application (2015-2020) Table 32. Global Biologics and Biosimilars Revenue (US$ Million) Market Share by Application (2015-2020) Table 33. Global Biologics and Biosimilars Price (K Units) by Application (2015-2020) Table 34. Global Biologics and Biosimilars Sales (K Units) by Application (2021-2026) Table 35. Global Biologics and Biosimilars Sales Share by Application (2021-2026) Table 36. Global Biologics and Biosimilars Revenue (US$ Million) Market Share by Application (2021-2026) Table 37. Global Biologics and Biosimilars Revenue Share by Application (2021-2026) Table 38. Global Biologics and Biosimilars Price (K Units) by Application (2021-2026) Table 39. United States Biologics and Biosimilars Sales (K Units) by Company (2015-2020) Table 40. United States Biologics and Biosimilars Sales Market Share by Company (2015-2020) Table 41. United States Biologics and Biosimilars Sales (K Units) by Type (2015-2020) Table 42. United States Biologics and Biosimilars Sales Market Share by Type (2015-2020) Table 43. United States Biologics and Biosimilars Sales (K Units) by Application (2015-2020) Table 44. United States Biologics and Biosimilars Sales Market Share by Application (2015-2020) Table 45. Europe Biologics and Biosimilars Sales (K Units) by Company (2015-2020) Table 46. Europe Biologics and Biosimilars Sales Market Share by Company (2015-2020) Table 47. Europe Biologics and Biosimilars Sales (K Units) by Type (2015-2020) Table 48. Europe Biologics and Biosimilars Sales Market Share by Type (2015-2020) Table 49. Europe Biologics and Biosimilars Sales (K Units) by Application (2015-2020) Table 50. Europe Biologics and Biosimilars Sales Market Share by Type (2015-2020) Table 51. China Biologics and Biosimilars Sales (K Units) by Company (2015-2020) Table 52. China Biologics and Biosimilars Sales Market Share by Company (2015-2020) Table 53. China Biologics and Biosimilars Sales (K Units) by Type (2015-2020) Table 54. China Biologics and Biosimilars Sales Market Share by Type (2015-2020) Table 55. China Biologics and Biosimilars Sales (K Units) by Application (2015-2020) Table 56. China Biologics and Biosimilars Sales Market Share by Application (2015-2020) Table 57. Japan Biologics and Biosimilars Sales (K Units) by Company (2015-2020) Table 58. Japan Biologics and Biosimilars Sales Market Share by Company (2015-2020) Table 59. Japan Biologics and Biosimilars Sales (K Units) by Type (2015-2020) Table 60. Japan Biologics and Biosimilars Sales Market Share by Type (2015-2020) Table 61. Japan Biologics and Biosimilars Sales (K Units) by Application (2015-2020) Table 62. Japan Biologics and Biosimilars Sales Market Share by Application (2015-2020) Table 63. Southeast Asia Biologics and Biosimilars Sales (K Units) by Company (2015-2020) Table 64. Southeast Asia Biologics and Biosimilars Sales Market Share by Company (2015-2020) Table 65. Southeast Asia Biologics and Biosimilars Sales (K Units) by Type (2015-2020) Table 66. Southeast Asia Biologics and Biosimilars Sales Market Share by Type (2015-2020) Table 67. Southeast Asia Biologics and Biosimilars Sales (K Units) by Type (2015-2020) Table 68. Southeast Asia Biologics and Biosimilars Sales Market Share by Application (2015-2020) Table 69. India Biologics and Biosimilars Sales (K Units) by Company (2015-2020) Table 70. India Biologics and Biosimilars Sales Market Share by Company (2015-2020) Table 71. India Biologics and Biosimilars Sales (K Units) by Type (2015-2020) Table 72. India Biologics and Biosimilars Sales Market Share by Type (2015-2020) Table 73. India Biologics and Biosimilars Sales (K Units) by Application (2015-2020) Table 74. India Biologics and Biosimilars Sales Market Share by Application (2015-2020) Table 75. Roche Corporation Information Table 76. Roche Description and Business Overview Table 77. Roche Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 78. Roche Biologics and Biosimilars Product Table 79. Roche Recent Development Table 80. Amgen Corporation Information Table 81. Amgen Description and Business Overview Table 82. Amgen Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 83. Amgen Biologics and Biosimilars Product Table 84. Amgen Recent Development Table 85. AbbVie Corporation Information Table 86. AbbVie Description and Business Overview Table 87. AbbVie Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 88. AbbVie Biologics and Biosimilars Product Table 89. AbbVie Recent Development Table 90. Sanofi-Aventis Corporation Information Table 91. Sanofi-Aventis Description and Business Overview Table 92. Sanofi-Aventis Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 93. Sanofi-Aventis Biologics and Biosimilars Product Table 94. Sanofi-Aventis Recent Development Table 95. Johnson & Johnson Corporation Information Table 96. Johnson & Johnson Description and Business Overview Table 97. Johnson & Johnson Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 98. Johnson & Johnson Biologics and Biosimilars Product Table 99. Johnson & Johnson Recent Development Table 100. Pfizer Corporation Information Table 101. Pfizer Description and Business Overview Table 102. Pfizer Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 103. Pfizer Biologics and Biosimilars Product Table 104. Pfizer Recent Development Table 105. Novo Nordisk Corporation Information Table 106. Novo Nordisk Description and Business Overview Table 107. Novo Nordisk Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 108. Novo Nordisk Biologics and Biosimilars Product Table 109. Novo Nordisk Recent Development Table 110. Eli Lilly Corporation Information Table 111. Eli Lilly Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 112. Eli Lilly Description and Business Overview Table 113. Eli Lilly Biologics and Biosimilars Product Table 114. Eli Lilly Recent Development Table 115. Novartis Corporation Information Table 116. Novartis Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 117. Novartis Description and Business Overview Table 118. Novartis Biologics and Biosimilars Product Table 119. Novartis Recent Development Table 120. Merck Corporation Information Table 121. Merck Description and Business Overview Table 122. Merck Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 123. Merck Biologics and Biosimilars Product Table 124. Merck Recent Development Table 125. 3sbio Corporation Information Table 126. 3sbio Description and Business Overview Table 127. 3sbio Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 128. 3sbio Biologics and Biosimilars Product Table 129. 3sbio Recent Development Table 130. Changchun High Tech Corporation Information Table 131. Changchun High Tech Description and Business Overview Table 132. Changchun High Tech Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 133. Changchun High Tech Biologics and Biosimilars Product Table 134. Changchun High Tech Recent Development Table 135. CP Guojian Corporation Information Table 136. CP Guojian Description and Business Overview Table 137. CP Guojian Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 138. CP Guojian Biologics and Biosimilars Product Table 139. CP Guojian Recent Development Table 140. Biotech Corporation Information Table 141. Biotech Description and Business Overview Table 142. Biotech Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 143. Biotech Biologics and Biosimilars Product Table 144. Biotech Recent Development Table 145. Gelgen Corporation Information Table 146. Gelgen Description and Business Overview Table 147. Gelgen Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 148. Gelgen Biologics and Biosimilars Product Table 149. Gelgen Recent Development Table 150. Innovent Corporation Information Table 151. Innovent Description and Business Overview Table 152. Innovent Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 153. Innovent Biologics and Biosimilars Product Table 154. Innovent Recent Development Table 155. Dong Bao Corporation Information Table 156. Dong Bao Description and Business Overview Table 157. Dong Bao Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 158. Dong Bao Biologics and Biosimilars Product Table 159. Dong Bao Recent Development Table 160. Ganlee Corporation Information Table 161. Ganlee Description and Business Overview Table 162. Ganlee Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 163. Ganlee Biologics and Biosimilars Product Table 164. Ganlee Recent Development Table 165. Production Base and Market Concentration Rate of Raw Material Table 166. Key Suppliers of Raw Materials Table 167. Biologics and Biosimilars Distributors List Table 168. Biologics and Biosimilars Customers List Table 169. Biologics and Biosimilars Market Key Trends Table 170. Biologics and Biosimilars Key Opportunities and Drivers Table 171. Biologics and Biosimilars Market Challenges Table 172. Research Programs/Design for This Report Table 173. Key Data Information from Secondary Sources Table 174. Key Data Information from Primary Sources List of Figures Figure 1. Biologics and Biosimilars Product Picture Figure 2. Global Biologics and Biosimilars Sales Market Share by Type in 2020 & 2026 Figure 3. Type I Product Picture Figure 4. Type II Product Picture Figure 5. Global Biologics and Biosimilars Market Share by Application in 2020 & 2026 Figure 6. Tumor Examples Figure 7. Diabetes Examples Figure 8. Cardiovascular Examples Figure 9. Hemophilia Examples Figure 10. Others Examples Figure 11. Global Biologics and Biosimilars Sales (K Units) Growth Rate (2015-2026) Figure 12. Global Biologics and Biosimilars Revenue (US$ Million) Growth Rate (2015-2026) Figure 13. Global Biologics and Biosimilars Price Trends Growth Rate (2015-2026) (USD/Unit) Figure 14. Global Biologics and Biosimilars Revenue Market Share by Region: 2015 VS 2020 Figure 15. Global Biologics and Biosimilars Revenue Market Share by Region: 2021 VS 2026 Figure 16. United States Biologics and Biosimilars Revenue (Million USD) Growth Rate (2015-2026) Figure 17. United States Biologics and Biosimilars Sales (K Units) Growth Rate (2015-2026) Figure 18. Europe Biologics and Biosimilars Revenue (Million USD) Growth Rate (2015-2026) Figure 19. Europe Biologics and Biosimilars Sales (Million USD) Growth Rate (2015-2026) Figure 20. China Biologics and Biosimilars Revenue (Million USD) Growth Rate (2015-2026) Figure 21. China Biologics and Biosimilars Sales (Million USD) and Growth Rate (2015-2026) Figure 22. Japan Biologics and Biosimilars Revenue (Million USD) Growth Rate (2015-2026) Figure 23. Japan Biologics and Biosimilars Sales (Million USD) Growth Rate (2015-2026) Figure 24. Southeast Asia Biologics and Biosimilars Revenue (Million USD) Growth Rate (2015-2026) Figure 25. Southeast Asia Biologics and Biosimilars Sales (Million USD) Growth Rate (2015-2026) Figure 26. India Biologics and Biosimilars Revenue (Million USD) Growth Rate (2015-2026) Figure 27. India Biologics and Biosimilars Sales (Million USD) Growth Rate (2015-2026) Figure 28. Global 5 Largest Biologics and Biosimilars Players Market Share by Revenue in Biologics and Biosimilars 2015 & 2019 Figure 29. Biologics and Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 30. Global Biologics and Biosimilars Revenue Share by Type (2015-2020) Figure 31. Global Biologics and Biosimilars Revenue Growth Rate by Type in 2015 & 2019 Figure 32. Global Biologics and Biosimilars Revenue Share by Application (2015-2020) Figure 33. Global Biologics and Biosimilars Revenue Growth Rate by Application in 2015 & 2019 Figure 34. United States Biologics and Biosimilars Sales Market Share by Type in 2019 Figure 35. United States Biologics and Biosimilars Sales Market Share by Type in 2019 Figure 36. Europe Biologics and Biosimilars Sales Market Share by Company in 2019 Figure 37. Europe Biologics and Biosimilars Sales Market Share by Type in 2019 Figure 38. Europe Biologics and Biosimilars Sales Market Share by Application in 2019 Figure 39. China Biologics and Biosimilars Sales Market Share by Company in 2019 Figure 40. China Biologics and Biosimilars Sales Market Share by Type in 2019 Figure 41. China Biologics and Biosimilars Sales Market Share by Application in 2019 Figure 42. Japan Biologics and Biosimilars Sales Market Share by Company in 2019 Figure 43. Japan Biologics and Biosimilars Sales Market Share by Type in 2019 Figure 44. Japan Biologics and Biosimilars Sales Market Share by Application in 2019 Figure 45. Southeast Asia Biologics and Biosimilars Sales Market Share by Company in 2019 Figure 46. Southeast Asia Biologics and Biosimilars Sales Market Share by Type in 2019 Figure 47. Southeast Asia Biologics and Biosimilars Sales Market Share by Application in 2019 Figure 48. India Biologics and Biosimilars Sales Market Share by Company in 2019 Figure 49. India Biologics and Biosimilars Sales Market Share by Type in 2019 Figure 50. India Biologics and Biosimilars Sales Market Share by Application in 2019 Figure 51. Key Raw Materials Price Trend Figure 52. Manufacturing Cost Structure of Biologics and Biosimilars Figure 53. Manufacturing Process Analysis of Biologics and Biosimilars Figure 54. Biologics and Biosimilars Industrial Chain Analysis Figure 55. Channels of Distribution Figure 56. Distributors Profiles Figure 57. Porter's Five Forces Analysis Figure 58. Bottom-up and Top-down Approaches for This Report Figure 59. Data Triangulation Figure 60. Key Executives Interviewed

Roche Amgen AbbVie Sanofi-Aventis Johnson & Johnson Pfizer Novo Nordisk Eli Lilly Novartis Merck 3sbio Changchun High Tech CP Guojian Biotech Gelgen Innovent Dong Bao Ganlee